Journal Guide

Focus and Scope

The Southern African Journal of Infectious Diseases (SAJID), formerly called the Southern African Journal of Epidemiology and Infection (SAJEI), first appeared in 1985 as a joint publication of the Infectious Diseases Society of Southern Africa (IDSSA), the Sexually Transmitted Diseases Society of Southern Africa (STDSSA) and the Epidemiology Society of Southern Africa, the latter having subsequently been succeeded by the Public Health Association of South Africa (PHASA). Presently SAJID is published under the auspices of the Federation of Infectious Diseases Societies of South Africa which is an umbrella organization incorporating IDSSA, STDSSA as well as the Infection Control Society of South Africa (ICASA), the National Antibiotic Study Forum (NASF) of South Africa, and the South African Society of Travel Medicine (SASTM).

Publications of SAJID centre round aspects of epidemiology and infection, particularly those of importance to the societies of FIDSSA. Topics around infection include clinical and epidemiological aspects of communicable diseases, laboratory diagnosis of infections, characterisation of infective agents by molecular techniques and the study of transmission patterns of pathogens in institutional and community settings. Other infection related studies cover surveillance of vaccine-controllable and other infectious diseases, drug susceptibility patterns of hospital-acquired and community-acquired pathogens and infection control strategies for the southern Africa region. SAJID also promotes greater collaboration between clinically oriented and laboratory-based divisions within the FIDSSA societies, and the establishment of quality assurance programmes and other measures to enhance and maintain standards of diagnostic and public health microbiology.

Scientific papers in the SAJID aim to advance the understanding of all aspects of epidemiology, public health, clinical microbiology and infection. The journal strives to promote research and exchange of information on specific areas of infectious diseases, medical microbiology and virology, covering fields of interest of the societies of FIDSSA and PHASA. Manuscripts describing research performed at southern African institutions and in southern African settings enjoy a high priority, as do health matters covering Africa and the developing world, as well as global issues such as malaria and other tropical diseases, tuberculosis, sexually transmitted infections and HIV/AIDS. The scope of interest of SAJID is wide but the journal aims to maintain and improve the standard of its publications.

The SAJID’s subscribes to the Uniform Requirements of the International Committee of Medical Journal Editors (ICMJE) (www. icmje.org). which state the ethical principles in the conduct and reporting of research and provide recommendations relating to specific elements of editing and writing.

Ethics

The SAJID abides by the high ethical standards of the Commission on Public Ethics (COPE) (www.publicationethics.org) and ICMJE. Falsification or fabrication of data, plagiarism, including duplicate publication of the author’s own work without proper citation, and misappropriation of the work are unacceptable practices.

Originality

SAJID will not publish manuscripts that overlap substantially with articles already published or accepted for publication, whether in print or the electronic media, even if the new submission contains data not included in the published or accepted work. This policy does not preclude consideration of a report that follows a presentation at a meeting/conference or expands preliminary findings published or presented as an abstract. Submissions for republication of articles must be accompanied by a statement that the article is republished with the knowledge of the author and Editor and the permission of the original copyright holder.

Plagiarism

Plagiarism, including duplicate publication of the author’s own work, in whole or in part without proper citation, will not be tolerated by the SAJID. If an attempt at undisclosed duplicate publication is identified, the article will be rejected, the owners of the copyright notified and the violation may be reported to FIDSSA or PHASA.

he Indian Journal of Medical Research (IJMR) [ISSN 0971-5916] is one of the oldest medical Journals not only in India, but probably in Asia, as it started in the year 1913. The Journal was started as a quarterly (4 issues/year) in 1913 and made bimonthly (6 issues/year) in 1958. It became monthly (12 issues/year) in the year 1964. The Journal is being indexed and abstracted by all major global current awareness and alerting services (Annexure). The IJMR is published monthly, in two volumes and 12 issues per year. The IJMR publishes peer reviewed quality biomedical research in the form of original research articles, review articles, short papers and short notes. Research letters are also published in the corresponding section after peer review. Supplements are published in addition to the regular issues Special issues. Criteria for consideration of papers - The papers should meet the following criteria – the material should be original, the methodology used should be standard and appropriate, results should be unambiguous supported with data/photographs, conclusions should be reasonable and based on the findings, the topic should be of biomedical interest and findings should have clinical significance. Papers involving human and animals should be ethically cleared by the local ethical committees. Manuscript Preparation - Manuscript should be prepared in accordance with the Guidelines set by the International Committee of Medical Journal Editors (ICMJE) as uniform requirements for manuscripts submitted to biomedical journals and should be submitted in triplicate (one original and 2 photocopies) with at least 2 sets of original Figures. Abstract should be structured (of about 250 words) under the subheadings Background & objectives, Methods, Results, and Interpretation & conclusions.All correspondence regarding submission of manuscripts, reprints, subscription etc., should be addressed to the.

The Journal of Immunology is a twice monthly peer-reviewed academic journal that publishes basic and clinical studies in all aspects of immunology. Established in 1916 it is the official journal of the American Association of Immunologists (AAI) which publishes the journal.

Published continuously since 1904, The Journal of Infectious Diseases (JID) is the premier global journal for original research on infectious diseases. The editors welcome Major Articles and Brief Reports describing research results on microbiology, immunology, epidemiology, and related disciplines, on the pathogenesis, diagnosis, and treatment of infectious diseases; on the microbes that cause them; and on disorders of host immune responses. JID is an official publication of the Infectious Diseases Society of America.

The Journal of Rheumatology is published monthly by The Journal of Rheumatology Publishing Company Limited. Manuscripts should be submitted via our Online Submission System.

The Lancet HIV launched in September 2014 as an exclusively online journal, publishing original research, expert commentary, informative editorials, and timely correspondence. The monthly journal provides readers with context and insight into the clinical advances and practice-changing research shaping the study of HIV/AIDS today.

Now is a critical moment in the fight against HIV/AIDS. Despite the world view that the end of AIDS may be within reach, the job of controlling this epidemic is certainly not done. As HIV disease evolves to become a chronic infection, the interaction of the virus with other chronic conditions will present a host of new challenges.The Lancet HIV is a journal for a new era in the history of HIV/AIDS.

The Lancet HIV builds onThe Lancet journals' reputation for publishing HIV/AIDS research to provide a reliable foundation for advocacy and for programmatic and political change. We will consider clinical, epidemiological, operational, and implementation research, unifying these disciplines across a single vision for the health of those living with HIV.

Following inThe Lancet tradition, the journal is stringently edited and peer-reviewed to ensure scientific merit and clinical relevance. All original research is Fast Track peer reviewed for online publication within 8 weeks of submission and receives global exposure to the medical HIV/AIDS community via our online platforms thelancet.com and ScienceDirect. For selected high-impact research, the journal has a dedicated press office to facilitate worldwide media coverage, ensuring extensive global exposure of your research.

Visit http://www.thelancet.com/hiv for more information.

Practical in both style and content, The Pediatric Infectious Disease Journal; delivers the latest insights on all aspects of infectious disease in children, from state-of-the-art diagnostic techniques to the most effective drug therapies and other essential treatment protocols. Website: www.pidj.com.

Tissue Antigens publishes full-length original articles, brief communications, commentaries and reviews covering all aspects of genetic control of immunity. The scope includes functional, biochemical, and genetic studies on molecules of the immune system, including cell surface receptors and their ligands, and encompassing cytokines, and chemokines, adhesion and co-stimulating molecules, antigen receptors such as TcR, NKR, CD1, PAMPs, Igs, and genes and products of the major histocompatibility complex including classical and non-classical HLA molecules. Papers should describe original research in vitro, or in animal models, or be clinical studies reflecting genetics of immunity in solid organ or bone marrow transplantation, autoimmunity, infectious immunity, allergy, tumour immunity, vaccine science, pregnancy and disease susceptibility. The journal emphasis is on understanding genetic control of immunity through:.

Transfusion is the foremost publication in the world for new information regarding transfusion medicine. Written by and for members of AABB and other health-care workers, Transfusion reports on the latest technical advances, discusses opposing viewpoints regarding controversial issues, and presents key conference proceedings. In addition to blood banking and transfusion medicine topics, Transfusion also presents submissions concerning tissue transplantation and hematopoietic, cellular, and gene therapies.

Transfusion Clinique et Biologique publishes original papers, general reviews, clinical cases, letters to the editor and editorials concerning transfusion activity in all its scientific and medical aspects.
Articles in English are also accepted.
In the CME section, update articles are published, together with self-evaluations and litterature reviews.

This journal is devoted to all areas of transfusion medicine. These include the quality and security of blood products, therapy with blood components and plasma derivatives, transfusion-related questions in transplantation, stem cell manipulation, therapeutic and diagnostic problems of hemostasis, immunohematological investigations, and legal aspects of the production of blood products as well as hemotherapy. Both comprehensive reviews and primary publications that detail the newest work in transfusion medicine and hemotherapy promote the international exchange of knowledge within these disciplines. Consistent with this goal, continuing clinical education is also specifically addressed.

Please bookmark this URL: http://www.elsevier.com/locate/trim

Benefits to authors
We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our http://www.elsevier.com/wps/find/authorsview.authors/authorservices author services .

Please see our http://www.elsevier.com/wps/find/journaldescription.cws_home/620925/authorinstructionsGuide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Transplant Infectious Disease has been established as a forum for presenting the most current information on the prevention and treatment of infection complicating organ and bone marrow transplantation. The point of view of the journal is that infection and allograft rejection (or graft-versus-host disease) are closely intertwined, and that advances in one area will have immediate consequences on the other. The interaction of the transplant recipient with potential microbial invaders, the impact of immunosuppressive strategies on this interaction, and the effects of cytokines, growth factors, and chemokines liberated during the course of infections, rejection, or graft-versus-host disease are central to the interests and mission of this journal. Transplant Infectious Disease is aimed at disseminating the latest information relevant to the infectious disease complications of transplantation to clinicians and scientists involved in bone marrow, kidney, liver, heart, lung, intestinal, and pancreatic transplantation. The infectious disease consequences and concerns regarding innovative transplant strategies, from novel immunosuppressive agents to xenotransplantation, are very much a concern of this journal. In addition, this journal feels a particular responsibility to inform primary care practitioners in the community, who increasingly are sharing the responsibility for the care of these patients, of the special considerations regarding the prevention and treatment of infection in transplant recipients. As exemplified by the international editorial board, articles are sought throughout the world that address both general issues and those of a more restricted geographic import. Transplant Infectious Disease includes state-of-the-art review articles on important subjects, the results of clinical investigation, interesting case reports, and two recurring features: a clinical-pathologic conference and reviews of the basic science foundation of transplant infectious disease. Subjects covered include specific infections, the epidemiology of important infections, the interaction among immunosuppression and infection exposure, the diagnosis of specific infection, pathogenesis, and clinical management. Both basic science and clinical articles are featured. Where controversy exists, both sides of an issue are presented. This journal is meant to serve the needs of all clinicians and scientists involved in the study and care of organ and bone marrow transplant recipients.

The most cited and influential journal in the field (with over 26,000 citations a year), Transplantation174; is published twice monthly and provides extensive coverage of the most important advances in transplantation. Using an electronic on-line submission and peer review tracking system, Transplantation174; is committed to rapid review and publication. The average time to first decision is now less than 21 days. Time to publication of accepted manuscripts continues to be shortened, with the Editorial team committed to a goal of 3 months from acceptance to publication.Consistently ranked among the top journals in Transplantation, Surgery and Immunology (2008 Journal Citation Reports), the journal covers areas including:Cell therapy and islet transplantationClinical transplantationExperimental transplantationImmunobiology and genomicsXenotransplantationExpert researchers and clinicians from around the world contribute original Articles, Overviews and Brief Reports in every pertinent specialty. Forums provide in-depth discussion of exciting developments and controversies in the field. Rapid Communications bring attention to cutting edge research.Issues also contain Analyses and Commentaries, Letters to the Editor and Announcements. Dedicated issues include the World Transplant Congress issue. Website: www.transplantjournal.com.

Aims and Scope:
Transplantation Proceedings publishes several different categories of manuscripts, all of which undergo extensive peer review by recognized authorities in the field prior to their acceptance for publication.

The first type of manuscripts consists of sets of papers providing an in-depth expression of the current state of the art in various rapidly developing components of world transplantation biology and medicine. These manuscripts emanate from congresses of the affiliated transplantation societies, from Symposia sponsored by the Societies, as well as special Conferences and Workshops covering related topics.

Transplantation Proceedings also publishes several special sections including publication of Clinical Transplantation Proceedings, being rapid original contributions of preclinical and clinical experiences. These manuscripts undergo review by members of the http://www.journals.elsevier.com/transplantation-proceedings/editorial-board/Editorial Board.

Transplantation Research is a peer-reviewed, open access, online journal that publishes articles on a broad range of topics in the discipline of transplantation. The content of this journal is directed towards both basic scientists and clinicians in this field, with the aim of informing all transplantation researchers and those interested in transplantation. Among the research topics included in Transplantation Research are:   organ preservation ischemia-reperfusion injury and inflammation histocompatibility pharmacological/experimental immunosuppression immune recognition - regulation, and tolerance induction strategies stem cell research for tissue regeneration/repair and immune regulation early-stage clinical trials and clinical trial protocols innovative method protocols complications of transplantation, including graft dysfunction, tissue repair, infections and posttransplant malignancy biomarker investigation organ donation and other ethical issues xenotransplantation. Types of transplantation primarily included are thoracic (heart and lung), abdominal (kidney, liver and pancreas) and tissue (islets, composite tissue). Transplantation Research emphasizes the publication of experimental research and pilot clinical trials that introduce new ideas and concepts to the field of transplantation.Transplantation Research is a forum for the quick release of cutting-edge experimental and clinical research in transplantation. Introduction of novel experimental concepts and early stage trial results are welcomed for publication and debate. As an open access online journal, Transplantation Research is in an optimal position to publish data and ideas with the least delay and with the greatest, exposure due to lack of restrictions regarding access. This represents a major new platform for transplantation researchers.

Benefits to authors
We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our http://www.elsevier.com/wps/find/authorsview.authors/authorservicesauthor services.

Please see our http://www.elsevier.com/wps/find/journaldescription.cws_home/623201/authorinstructionsGuide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

medline.jpg

For more information, go to http://www.cell.com/trends/immunology

Trials in Vaccinology is a new peer-reviewed online-only journal that will guarantee direct public access to the results of vaccine trials in humans and target animals, especially those of whose scientific novelty is not exceptional, and thus increase the transparency of current supportive scientific research in the field of vaccines. It will also provide opportunities for those engaged in these trials to gain recognition for their work and for those who use or comment on the value of vaccines to gain additional evidence to further hone their understandings.The objective of this journal is to be inclusive and supportive, and not to select only those trials that make innovative contributions to the field of vaccinology; these latter papers will find their home in the journal "Vaccine"http://www.elsevier.com/locate/vaccineTrials in Vaccinology will provide a facility that will enable both vaccinologists and those interested in the use of vaccines to gain insights and understandings of the breadth and depth of evidence that is available for the appreciation of the properties of a vaccine and its place in the healthcare and animal husbandry systems that are used in different countries and with particular cohorts of vaccinees.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com